CureVac N.V. (CVAC)
NASDAQ: CVAC · Real-Time Price · USD
3.300
+0.020 (0.61%)
At close: Feb 21, 2025, 4:00 PM
3.320
+0.020 (0.61%)
After-hours: Feb 21, 2025, 6:05 PM EST
CureVac Market Cap
CureVac has a market cap or net worth of $740.24 million as of February 21, 2025. Its market cap has decreased by -6.88% in one year.
Market Cap
740.24M
Enterprise Value
565.07M
1-Year Change
-6.88%
Ranking
Category
Stock Price
$3.30
Market Cap Chart
Since the IPO on August 14, 2020, CureVac's market cap has decreased from $9.84B to $740.24M, a decrease of -92.47%. That is a compound annual growth rate of -43.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 740.24M | -3.23% |
| Dec 31, 2024 | 764.91M | -18.86% |
| Dec 29, 2023 | 942.72M | -17.82% |
| Dec 30, 2022 | 1.15B | -82.12% |
| Dec 31, 2021 | 6.42B | -55.14% |
| Dec 31, 2020 | 14.31B | 45.43% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |